Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes

Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes

BackgroundLimited data exist on the burden of myeloproliferative, lymphocytic and idiopathic subtypes of hypereosinophilic syndrome (M-HES, L-HES and I-HES) and the characteristics of patients with HES receiving biologic therapies. This analysis aimed to further characterize these subtypes and explo...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeremiah Hwee, Lynn Huynh, Wilson da Costa, Marc E. Rothenberg, Mei Sheng Duh, Rafael Alfonso-Cristancho
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Allergy
Subjects:
hypereosinophilic syndrome
burden of disease
biologics
mepolizumab
retrospective study
corticosteroid
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2025.1605397/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2025.1605397/full

Similar Items